bf/NASDAQ:BIIB_icon.jpeg

NASDAQ:BIIB

Biogen Inc.

  • Stock

USD

Last Close

230.04

17/05 16:09

Market Cap

35.47B

Beta: 0.19

Volume Today

381.59K

Avg: 876.67K

PE Ratio

24.00

PFCF: 34.22

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
553.19M
-
731.51M
32.24%
848.71M
16.02%
947.50M
11.64%
952.15M
0.49%
916.30M
3.77%
867.05M
5.37%
936.40M
8.00%
1.21B
29.22%
1.35B
11.40%
average payables
211.96M
-
224.55M
5.94%
248.29M
10.57%
273.60M
10.19%
337.65M
23.41%
383M
13.43%
450.65M
17.66%
492.85M
9.36%
522.05M
5.92%
540.35M
3.51%
average receivables
755.63M
-
1.06B
40.07%
1.26B
19.02%
1.33B
5.92%
1.61B
20.98%
1.87B
16.01%
1.92B
2.50%
1.90B
1.16%
1.73B
8.73%
1.84B
6.43%
book value per share
36.39
-
45.75
25.74%
40.64
11.18%
55.53
36.66%
59.26
6.70%
63.60
7.33%
71.29
12.10%
66.41
6.84%
73.51
10.68%
92.14
25.36%
capex per share
-14.81
-
-1.22
91.78%
-2.79
128.94%
-3.33
19.55%
-9.23
177.09%
-4.32
53.16%
-3.58
17.26%
-3.43
4.16%
-1.98
42.33%
-1.67
15.37%
capex to depreciation
-6.60
-
-0.42
93.66%
-1.07
156.12%
-1.07
0.47%
-1.82
70.34%
-0.87
52.00%
-0.98
12.86%
-1.21
22.69%
-0.60
49.90%
-0.47
22.42%
capex to operating cash flow
-1.50
-
-0.10
93.46%
-0.17
76.92%
-0.16
7.00%
-0.43
168.03%
-0.14
66.80%
-0.09
33.95%
-0.13
37.93%
-0.08
37.90%
-0.18
116.84%
capex to revenue
-0.51
-
-0.03
94.14%
-0.06
101.44%
-0.06
6.40%
-0.16
151.59%
-0.07
58.81%
-0.05
29.31%
-0.04
11.86%
-0.03
34.57%
-0.02
10.98%
0.03
217.81%
cash per share
5.16
-
7.81
51.28%
14.86
90.35%
22.41
50.82%
17.35
22.58%
17.27
0.49%
23.92
38.54%
16.22
32.19%
25.50
57.21%
33.67
32.04%
days of inventory on hand
280.43
-
250.61
10.64%
262.89
4.90%
247.23
5.96%
202.14
18.24%
186.87
7.55%
150.11
19.67%
216.06
43.93%
233.82
8.22%
215.38
7.89%
days payables outstanding
93.58
-
71.43
23.67%
78.69
10.15%
69.07
12.23%
88.56
28.23%
74.45
15.93%
99.08
33.07%
91.98
7.17%
101.94
10.83%
78.74
22.75%
days sales outstanding
43.41
-
48.62
12.00%
41.61
14.42%
45.96
10.46%
53.14
15.63%
53.14
0.01%
47.74
10.16%
51.96
8.84%
51.50
0.88%
76.65
48.84%
debt to assets
0.05
-
0.04
18.63%
0.33
718.58%
0.28
14.86%
0.25
11.88%
0.23
6.50%
0.23
0.40%
0.32
36.00%
0.32
0.15%
0.27
15.41%
debt to equity
0.07
-
0.05
21.72%
0.70
1,186.43%
0.54
22.81%
0.47
12.28%
0.46
3.35%
0.48
4.79%
0.73
53.46%
0.69
5.30%
0.49
28.79%
dividend yield
1.01
-
0.68
32.14%
0.08
87.72%
0.00
-
0.00
83.24%
earnings yield
0.03
-
0.04
30.10%
0.05
37.20%
0.06
19.13%
0.04
37.29%
0.07
91.68%
0.11
47.60%
0.10
4.26%
0.04
57.16%
0.08
74.08%
enterprise value
66.23B
-
79.61B
20.21%
75.89B
4.68%
66.12B
12.87%
72.09B
9.03%
66.37B
7.93%
58.97B
11.15%
45.89B
22.17%
41.11B
10.42%
43.43B
5.64%
enterprise value over ebitda
23.59
-
18.30
22.43%
13.74
24.89%
10.11
26.46%
11.05
9.28%
9.67
12.42%
7.84
18.93%
9.55
21.72%
11.24
17.77%
16.17
43.80%
ev to operating cash flow
28.24
-
27.06
4.19%
20.42
24.53%
14.62
28.41%
15.84
8.34%
10.73
32.29%
8.33
22.33%
10.85
30.24%
11.30
4.10%
31.37
177.76%
ev to sales
9.55
-
8.20
14.12%
7.05
14.07%
5.78
18.09%
5.87
1.70%
4.93
16.00%
4.10
16.86%
3.41
16.77%
3.74
9.67%
4.27
14.03%
free cash flow per share
-4.91
-
11.23
328.59%
13.32
18.62%
17.38
30.44%
12.17
29.93%
25.87
112.53%
34.25
32.39%
22.86
33.27%
22.43
1.86%
7.85
64.99%
free cash flow yield
-0.02
-
0.03
288.27%
0.04
31.43%
0.06
40.91%
0.04
37.63%
0.09
125.00%
0.12
34.26%
0.09
19.13%
0.09
0.16%
0.03
69.67%
graham net net
-4.52
-
-1.21
73.28%
-23.12
1,812.35%
-19.56
15.42%
-26.22
34.06%
-33.12
26.31%
-40.66
22.77%
-58.13
42.98%
-48.81
16.04%
-27.52
43.62%
graham number
80.22
-
113.06
40.93%
118.57
4.87%
145.55
22.76%
126.19
13.30%
175.91
39.40%
224.69
27.73%
192.76
14.21%
131.38
31.84%
208.51
58.70%
income quality
1.26
-
1.00
20.57%
1.03
3.40%
1.22
18.32%
1.70
39.29%
1.38
18.86%
1.20
13.08%
1.04
13.34%
2.11
102.26%
0.47
77.82%
intangibles to total assets
0.48
-
0.40
15.96%
0.35
14.43%
0.33
5.53%
0.36
10.10%
0.35
3.02%
0.34
2.32%
0.36
5.40%
0.33
6.96%
0.31
7.43%
0
100%
interest coverage
78.86
-
134.66
70.76%
51.21
61.97%
19.81
61.32%
21.31
7.57%
29.35
37.76%
37.58
28.02%
20.45
45.58%
11.20
45.22%
9.41
16.00%
interest debt per share
2.65
-
2.60
1.86%
28.70
1,003.67%
31.03
8.11%
29.11
6.19%
29.95
2.89%
35.03
16.97%
50.04
42.82%
52.70
5.32%
47.22
10.40%
inventory turnover
1.30
-
1.46
11.90%
1.39
4.67%
1.48
6.33%
1.81
22.31%
1.95
8.17%
2.43
24.49%
1.69
30.52%
1.56
7.60%
1.69
8.56%
invested capital
0.07
-
0.05
21.72%
0.70
1,186.43%
0.54
22.81%
0.47
12.28%
0.46
3.35%
0.48
4.79%
0.73
53.46%
0.69
5.30%
0.49
28.79%
market cap
66.24B
-
80.23B
21.13%
70.67B
11.91%
61.93B
12.37%
67.73B
9.36%
61.66B
8.96%
55.52B
9.96%
39.40B
29.04%
35.77B
9.20%
40.24B
12.48%
net current asset value
-57.56M
-
1.17B
2,132.82%
-3.43B
393.09%
-2.02B
41.22%
-3.18B
57.80%
-4.62B
45.12%
-5.51B
19.43%
-7.05B
27.79%
-5.06B
28.17%
-1.37B
72.84%
net debt to ebitda
-0.00
-
-0.14
5,927.17%
0.94
762.91%
0.64
32.23%
0.67
4.42%
0.69
2.78%
0.46
33.12%
1.35
194.21%
1.46
8.10%
1.19
18.59%
net income per share
7.86
-
12.42
57.96%
15.37
23.83%
16.95
10.27%
11.94
29.56%
21.62
81.06%
31.47
45.55%
24.86
21.00%
10.44
58.02%
20.97
100.92%
operating cash flow per share
9.90
-
12.45
25.76%
16.11
29.41%
20.71
28.55%
21.41
3.38%
30.20
41.07%
37.83
25.28%
26.29
30.52%
24.41
7.14%
9.53
60.97%
payables turnover
3.90
-
5.11
31.01%
4.64
9.22%
5.28
13.93%
4.12
22.02%
4.90
18.95%
3.68
24.85%
3.97
7.72%
3.58
9.77%
4.64
29.46%
receivables turnover
8.41
-
7.51
10.71%
8.77
16.85%
7.94
9.47%
6.87
13.51%
6.87
0.01%
7.65
11.31%
7.03
8.12%
7.09
0.89%
4.76
32.81%
research and ddevelopement to revenue
0.21
-
0.20
6.33%
0.19
4.17%
0.17
7.83%
0.18
6.53%
0.19
5.15%
0.16
17.84%
0.30
87.14%
0.23
23.27%
0.22
3.71%
0.25
14.14%
return on tangible assets
0.30
-
0.34
13.75%
0.28
19.20%
0.24
13.53%
0.17
30.26%
0.27
60.49%
0.33
21.89%
0.25
22.69%
0.10
61.40%
0.18
83.56%
revenue per share
29.26
-
41.05
40.31%
46.66
13.65%
52.42
12.35%
57.73
10.13%
65.66
13.72%
76.85
17.04%
83.56
8.74%
73.65
11.85%
70.02
4.94%
roe
0.22
-
0.27
25.63%
0.38
39.41%
0.31
19.31%
0.20
33.98%
0.34
68.69%
0.44
29.84%
0.37
15.19%
0.14
62.07%
0.23
60.28%
roic
0.21
-
0.26
26.24%
0.23
10.89%
0.21
11.05%
0.15
27.47%
0.24
56.85%
0.29
24.52%
0.19
34.08%
0.15
24.54%
0.09
35.54%
sales general and administrative to revenue
shareholders equity per share
36.39
-
45.75
25.74%
40.64
11.18%
55.53
36.66%
59.26
6.70%
63.60
7.33%
71.29
12.10%
66.41
6.84%
73.51
10.68%
92.14
25.36%
stock based compensation to revenue
0.02
-
0.02
18.59%
0.01
6.31%
0.01
9.83%
0.01
22.87%
0.01
12.26%
0.01
8.30%
0.01
16.33%
0.02
47.31%
0.02
14.96%
tangible asset value
2.91B
-
5.03B
72.50%
2.63B
47.74%
4.65B
77.11%
4.09B
12.15%
4.21B
2.92%
4.05B
3.60%
1.84B
54.62%
2.98B
61.84%
5.79B
94.45%
tangible book value per share
12.30
-
21.26
72.91%
11.38
46.46%
21.30
87.09%
19.22
9.75%
20.52
6.78%
21.67
5.57%
11.43
47.23%
19.97
74.64%
39.84
99.53%
working capital
1.43B
-
2.45B
71.94%
4.12B
68.07%
5.40B
30.87%
4.51B
16.50%
4.35B
3.54%
3.52B
19.05%
3.14B
10.61%
3.56B
13.15%
6.52B
83.19%

All numbers in USD (except ratios and percentages)